Research

Publications

Gruber I, Kollerits B, Forer L, …, Schultheiss UTKöttgen A, Eckardt KU, Coassin S, Lamina C, Kronenberg F. Lipoprotein(a) concentrations and cardiovascular disease in patients with chronic kidney disease: Results from the German Chronic Kidney Disease study. J Intern Med (2024). Ferrarese R, Joseph K, Andrieux G, …, Prinz M, Ravi VM, Boerries M, Heiland DH, Carro MS. ZBTB18 regulates cytokine expression and affects microglia/macrophage recruitment and commitment in glioblastoma. Commun Biol (2024). Vogele D, Wöhrle S, Saller BS, Fröhlich K, Barta BA, Cosenza-Contreras M, Groß O, Schilling O. Size exclusion chromatography based proteomic and degradomic profiling of inflammasome-activated, murine bone marrow-derived dendritic cells highlights complex retention and release of cleavage products. Mol Omics (2024). Salié H, Wischer L, D’Alessio A, …, Boerries M, …, Hofmann M, Thimme R, Pinato DJ, Longerich T, Bengsch B. Spatial single-cell profiling and neighbourhood analysis reveal the determinants of immune architecture connected to checkpoint inhibitor therapy outcome in hepatocellular carcinoma. Gut (2024). Eble J, Köttgen ASchultheiss UT. Monogenic Kidney Diseases in Adults With Chronic Kidney Disease (CKD). Dtsch Arztebl Int (2024). Dannenberg F, von Moers A, Bittigau P, …, Broekema MF, Schuelke M, Kaindl AM, Scholl U, Ortner NJ. A Novel De Novo Gain-of-Function CACNA1D Variant in Neurodevelopmental Disease With Congenital Tremor, Seizures, and Hypotonia. Neurol Genet (2024). Grahammer F, Dumoulin B, Gulieva RE, Arnold F, …, Freedman BS, Busch H, Boerries MWalz G, Huber TB. Cyclin-dependent kinase 4 drives cystic kidney disease in the absence of mTORC1 signaling activity. Kidney Int (2024). Schmidt IM, Surapaneni AL, Zhao R, …, Schlosser P, …, Coresh J, Kidney Precision Medicine Project, Rhee EP, Grams ME, Waikar SS. Plasma proteomics of acute tubular injury. Nat Commun (2024). Li LV, Xiao S, Schlosser PScherer N, Wiggenhorn AL, Spaas J, Tung ASH, Karoly ED, Köttgen A, Long JZ. SLC17A1/3 transporters mediate renal excretion of Lac-Phe in mice and humans. Nat Commun (2024). Cosenza-Contreras M, Seredynska A, Vogele D, …, Huesgen PF, Kuehn EW, Kreutz C, Schell CSchilling O. TermineR: Extracting information on endogenous proteolytic processing from shotgun proteomics data. Proteomics (2024). Hoefele J, Eble J, Hermle TWuttke MSchultheiss UT. Extrarenal manifestations in inherited kidney diseases. Nephrol Dial Transplant (2024). Schmidts M, Qader MA. The Many Faces of Congenital Anomalies of the Kidney and Urinary Tract. Kidney Int Rep (2024). Patil S, Borisov O, Scherer N, Wirth C, Schlosser PWuttke M, …, Eckardt KU, Hunte C, Neubauer B, Köttgen AKöttgen M. The membrane transporter SLC25A48 enables transport of choline into human mitochondria. Kidney Int (2024). Buckley M, Terwagne C, Ganner A, …, Diederichs SNeumann-Haefelin E, Turajlic S, Ivakine EA, Findlay GM. Saturation genome editing maps the functional spectrum of pathogenic VHL alleles. Nat Genet (2024). Arnold F, Kupferschmid L, Weissenborn P, …, Zareba P, Sagar, Rogg M, Schell CTanriver Y. Tissue-resident memory T cells break tolerance to renal autoantigens and orchestrate immune-mediated nephritis. Cell Mol Immunol (2024). Talvard-Balland N, Braun LM, Dixon KO, …, Köttgen A, …, Börries M, …, Becher B, Köhler N, Wertheimer T, Kuchroo VK, Zeiser R. Oncogene induced TIM-3 ligand expression dictates susceptibility to anti-TIM-3 therapy in mice. J Clin Invest (2024).